Our Approach
AI-driven personalised medicine at scale
We combine advanced AI with deep medical expertise to find what actually works for each patient — and to do it at scale.
Uncovering new drug targets
Finding opportunities for drug repurposing
Speeding up and reducing risks in clinical development
Creating precise diagnostics and clinical decision support tools
Delivering personalised therapeutic solutions
Our breakthrough approach combines advanced AI with deep medical expertise to uncover treatment opportunities that actually work for individual patients. We dive deeper into the biology behind chronic diseases than anyone else, identifying distinct patient groups that traditional medicine often misses.
This detailed understanding helps us find new drug targets, repurpose existing medications more effectively, and develop biomarkers that tell us exactly which patients will respond to specific treatments. Instead of hoping a treatment might work, we can predict with confidence who will benefit most.
Our platform doesn’t just analyse data; it reveals the unique biological story of each patient’s condition, enabling doctors to make truly informed decisions about personalised care — better outcomes, fewer side effects, and treatments tailored to how each person’s body works.
Speed, precision, and scalability at the core
What once took months or years, we now achieve in days. CureLogic’s fully integrated AI-CRISPR platform accelerates the process from early-stage discovery to patient-ready solutions — providing faster outcomes with scientific accuracy.
Advancing personalised treatments from discovery to clinic
Discovery
Development
Diagnosis
Treatment
We streamline the journey from molecular discovery to clinical application through our AI-driven miRNA therapeutics platform. By integrating advanced CRISPR profiling, intelligent imaging, and robotic synthesis, we rapidly develop and validate personalised treatments tailored to each patient’s unique biological profile — accelerating timelines while ensuring precision, scalability, and real-world impact.
Target discovery
AI-powered identification of novel miRNA targets and new therapeutic opportunities through deep patient stratification using molecular biomarkers.
Therapeutic development
Advanced biomarker profiling to predict patient response and optimise clinical trial outcomes by selecting likely responders.
Personalised diagnostics
Personalised diagnostic insights powered by combinatorial biomarker analysis and miRNA risk profiling for early, accurate detection.
Treatment
Tailored therapeutic recommendations supported by real-time clinical decision tools and personalised digital health platforms.
Want to work with the minds shaping the future of healthcare?
Join forces with our experts.